Visit the RepliCel Life Sciences Investor Hub
RepliCel Life Sciences Inc. (TSXV: RP) President and CEO David Hall explains the process by which his company is working on treatments for chronic tendinosis, sun-damaged skin, and male pattern baldness with the safe use of a patient’s own cells. He also describes how RepliCel is creating value for its shareholders by advancing its products through clinical trials as well as with a licensing agreement with the world’s third-largest cosmetic company.
To get breaking news and interviews with the company, follow RepliCel Life Sciences Inc. News
RepliCel Life Sciences Inc. is a featured sponsored company and has paid SmallCapPower.com a fee for coverage.
